| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/2011 | US20110190292 Heterobicyclic compounds useful as kinase inhibitors |
| 08/04/2011 | US20110190291 Prodrug and Fluoregenic Compositions and Methods for Using the Same |
| 08/04/2011 | US20110190290 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 08/04/2011 | US20110190289 Imidazolothiadiazoles for Use as Protein Kinase Inhibitors |
| 08/04/2011 | US20110190288 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) for use in treatment of diseases associated with a pten deficiency |
| 08/04/2011 | US20110190287 Thrombocyte Inhibition Via Vivo-Morpholino Knockdown of Alpha IIB |
| 08/04/2011 | US20110190286 Therapeutically active cyclopentanes |
| 08/04/2011 | US20110190285 Methods of treating a botulinum toxin related condition in a subject |
| 08/04/2011 | US20110190284 Aerosol formulations for the inhalation of beta-agonists |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190282 Novel vegf-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 08/04/2011 | US20110190281 Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis |
| 08/04/2011 | US20110190280 Thiazole And Oxazole Kinase Inhibitors |
| 08/04/2011 | US20110190279 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
| 08/04/2011 | US20110190278 Bicyclic heterocyclic derivative |
| 08/04/2011 | US20110190277 Pharmaceutical combination for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 08/04/2011 | US20110190276 Pyridine Derivatives And Their Use In The Treatment Of Psychotic Disorders |
| 08/04/2011 | US20110190275 C2-fluoro substituted piperazine linked pyrrolo[2,1-c][1,4] benzodiazepine dimers and a process for the preparation thereof |
| 08/04/2011 | US20110190274 Salt of, and processes for the preparation of, 1-isopropyl-4-hexahydro-1h-1,4-diazepine |
| 08/04/2011 | US20110190273 Methods and compositions in the treatment of coronaviruses |
| 08/04/2011 | US20110190272 Chemical compounds |
| 08/04/2011 | US20110190271 2,4-Pyrimidinediamine Compounds and Uses as Anti-Proliferative Agents |
| 08/04/2011 | US20110190270 Methods of treating thromboembolic disorders |
| 08/04/2011 | US20110190269 Gamma secretase modulators |
| 08/04/2011 | US20110190268 Novel Benzimidazole Linked Pyrrolo[2,1-c[1,4] Benzodiazepine Hybrids as Potential Antitumour Agents and Process for the Preparation Thereof |
| 08/04/2011 | US20110190267 Prodrugs of opioids and uses thereof |
| 08/04/2011 | US20110190266 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) |
| 08/04/2011 | US20110190265 Methods and compositions for treating bacterial infections by inhibiting quorum sensing |
| 08/04/2011 | US20110190264 Compounds and compositions as kinase inhibitors |
| 08/04/2011 | US20110190263 Compounds and compositions as modulators of gpr119 activity |
| 08/04/2011 | US20110190262 Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/04/2011 | US20110190261 MAPK/ERK Kinase Inhibitors |
| 08/04/2011 | US20110190260 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/04/2011 | US20110190259 Compounds and compositions as protein kinase inhibitors |
| 08/04/2011 | US20110190258 Aryl benzylamine compounds |
| 08/04/2011 | US20110190257 Bicyclic heterocycles as mek kinase inhibitors |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190255 Heterocyclic compounds |
| 08/04/2011 | US20110190254 Cephalosporin having catechol group |
| 08/04/2011 | US20110190253 Method for treating tuberculosis |
| 08/04/2011 | US20110190252 Compositions including clavulanic acid and related methods of use |
| 08/04/2011 | US20110190251 Method for inhibiting the build-up of arterial plaque by administering fullerenes |
| 08/04/2011 | US20110190250 Eye drop with difluprednate for macular edema treatment |
| 08/04/2011 | US20110190249 Therapeutic methods and uses of sapogenins and their derivatives |
| 08/04/2011 | US20110190248 Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/04/2011 | US20110190247 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 08/04/2011 | US20110190246 Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring |
| 08/04/2011 | US20110190245 Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety |
| 08/04/2011 | US20110190244 Method of treatment of egfr inhibitor toxicity |
| 08/04/2011 | US20110190243 Diagnosis and treatment of back pain |
| 08/04/2011 | US20110190242 Compositions and methods for the treatment of inflammatory disease |
| 08/04/2011 | US20110190241 Targeting an hiv-1 nef-host cell kinase complex |
| 08/04/2011 | US20110190240 Nuclear factor kappa b pathway inhibitor composition and use of same |
| 08/04/2011 | US20110190239 Bmi-1 protein expression modulators |
| 08/04/2011 | US20110190238 Modifications of solid 3-sn-phosphoglycerides |
| 08/04/2011 | US20110190237 Macrocyclic Prodrug Compounds Useful as Therapeutics |
| 08/04/2011 | US20110190236 Chemical compounds |
| 08/04/2011 | US20110190235 Boron-containing small molecules as antiprotozoal agents |
| 08/04/2011 | US20110190234 MYCOBACTERIUM MEMBRANE PROTEASE AS A TARGET FOR INHIBITORS OF INTRABACTERIAL pH HOMEOSTASIS |
| 08/04/2011 | US20110190233 Anionic conjugates of glycosylated bacterial metabolite |
| 08/04/2011 | US20110190230 Betalain Compositions and Uses Thereof |
| 08/04/2011 | US20110190227 Antagonists of Prostaglandin D2 Receptors |
| 08/04/2011 | US20110190226 C4'-substituted-2-deoxyadenosine analogs and methods of treating hiv |
| 08/04/2011 | US20110190225 Topical method for prompt relief of severe ascites |
| 08/04/2011 | US20110190222 Selective Inhibition of Polyglutamine Protein Expression |
| 08/04/2011 | US20110190220 Use of Defensin Alpha 1 and/or Defensin Alpha 4, as a Marker for Predicting Treatment Response and/or a Relapse in a Patient Suffering form Chronic Myeloid Leukemia |
| 08/04/2011 | US20110190216 Materials and methods for treatment of spinal muscular atrophy and taxane-induced peripheral neuropathy (tipn) |
| 08/04/2011 | US20110190206 Reducing myocardial reperfusion injury by the combination therapy of protein kinase a activation and b1-adrenergic receptor blockade |
| 08/04/2011 | US20110190201 Method, device, and kit for maintaining physiological levels of steroid hormone in a subject |
| 08/04/2011 | US20110190199 Combination Therapy for Tuberculosis |
| 08/04/2011 | US20110189318 Methods for enhancing the expression of intracellular redox-associated factors |
| 08/04/2011 | US20110189312 Compositions and Methods for Supporting Heat Shock Protein Function |
| 08/04/2011 | US20110189311 Highly Absorbable Drug Composition and Method of Producing the Same |
| 08/04/2011 | US20110189310 Small molecule modulators of prongf uptake |
| 08/04/2011 | US20110189308 Methods to treat neurodegenerative conditions or diseases by targeting components of a pten signaling pathway |
| 08/04/2011 | US20110189307 Methods and compositions for oxygenation of skin to treat skin disorders |
| 08/04/2011 | US20110189306 COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES |
| 08/04/2011 | US20110189305 Treatment of lung cancer |
| 08/04/2011 | US20110189304 Absorbable implants and methods for their use in hemostasis and in the treatment of osseous defects |
| 08/04/2011 | US20110189300 siRNA SILENCING OF APOLIPOPROTEIN B |
| 08/04/2011 | US20110189299 Pharmaceutical composition containing surface-coated microparticles |
| 08/04/2011 | US20110189297 Stable solid oral dosage co-formulations |
| 08/04/2011 | US20110189295 Telmisartan tablets |
| 08/04/2011 | US20110189293 Therapeutic regimens for the treatment of immunoinflammatory disorders |
| 08/04/2011 | US20110189292 Dermal fillers comprising silk fibroin hydrogels and uses thereof |
| 08/04/2011 | US20110189291 Dendrimer hydrogels |
| 08/04/2011 | US20110189288 Diethylstilbestrol dosage form and methods of treatment |
| 08/04/2011 | US20110189287 Methods and compositions for wound healing |
| 08/04/2011 | US20110189286 Pulsatile Release of Valsartan |
| 08/04/2011 | US20110189283 Appetising medicaments for oral administration in solid form for prevention and/or treatment of cardiac insufficiency in animals |
| 08/04/2011 | US20110189281 Telmisartan and hydrochlorothiazide combination therapy |
| 08/04/2011 | US20110189280 Dosage form comprising 1-isopropyl-4-hexahydro-1h-1,4-diazepine or a salt thereof |
| 08/04/2011 | US20110189279 Pharmaceutical compositions with modified release properties comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid |
| 08/04/2011 | US20110189278 Pterostilbene cocrystals |
| 08/04/2011 | US20110189277 Pterostilbene cocrystals |
| 08/04/2011 | US20110189276 Pterostilbene cocrystals |
| 08/04/2011 | US20110189275 Pterostilbene cocrystals |
| 08/04/2011 | US20110189274 Stable Pharmaceutical Compositions Of Montelukast Or Its Salts Or Solvates Or Hydrates |
| 08/04/2011 | US20110189273 Amantadine compositions and methods of use |
| 08/04/2011 | US20110189272 Pharmaceutical preparation containing gabapentin |